In summary, shRNA interference technology will be used to affect the expression of CDCA5, explore the effect of CDCA5 expression on the proliferation and metastasis of TNBC cancer cells, and find new potential targets for the subsequent clinical treatment of TNBC. Here, CDCA5 is linked to cancer.